Elaine Sorg
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Elaine K.
Sorg is Director at Artiva Biotherapeutics, Inc. since 2026.
Ms. Sorg is Independent Non-Executive Director at CSL Ltd. since 2024.
Ms. Sorg was Senior VP & President-US Commercial Operations at AbbVie, Inc. from 2020 to 2024.
Ms. Sorg completed graduate studies at Harvard Business School and the University of Chicago Booth School of Business.
Ms. Sorg completed undergraduate studies at Purdue University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CSL LIMITED | Director/Miembro de la Junta | 01/09/2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 19/02/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.